Mark L. Berch

Array ( [id] => 7281561 [patent_doc_number] => 20040063938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Process for preparing haloalkyl pyrimidines' [patent_app_type] => new [patent_app_number] => 10/458702 [patent_app_country] => US [patent_app_date] => 2003-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5594 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063938.pdf [firstpage_image] =>[orig_patent_app_number] => 10458702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 516293 [patent_doc_number] => 07192962 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-20 [patent_title] => 'Xanthine phosphodiesterase V inhibitor polymorphs' [patent_app_type] => utility [patent_app_number] => 10/449650 [patent_app_country] => US [patent_app_date] => 2003-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10497 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/192/07192962.pdf [firstpage_image] =>[orig_patent_app_number] => 10449650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5662180 [patent_doc_number] => 20060252776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'Novel crystalline forms of valacyclovir hydrochloride' [patent_app_type] => utility [patent_app_number] => 10/558243 [patent_app_country] => US [patent_app_date] => 2003-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3520 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20060252776.pdf [firstpage_image] =>[orig_patent_app_number] => 10558243 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 691541 [patent_doc_number] => 07074923 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-11 [patent_title] => 'Process for preparing xanthine phosphodiesterase V inhibitors and precursors thereof' [patent_app_type] => utility [patent_app_number] => 10/449526 [patent_app_country] => US [patent_app_date] => 2003-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8429 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/074/07074923.pdf [firstpage_image] =>[orig_patent_app_number] => 10449526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7265327 [patent_doc_number] => 20040242863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Preparation of cefalosporins intermediates and conversion of said intermediates into active compound precursors' [patent_app_type] => new [patent_app_number] => 10/445296 [patent_app_country] => US [patent_app_date] => 2003-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6647 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242863.pdf [firstpage_image] =>[orig_patent_app_number] => 10445296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 750054 [patent_doc_number] => 07022686 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-04 [patent_title] => 'A1 adenosine receptro antagonists' [patent_app_type] => utility [patent_app_number] => 10/446573 [patent_app_country] => US [patent_app_date] => 2003-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9585 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/022/07022686.pdf [firstpage_image] =>[orig_patent_app_number] => 10446573 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730788 [patent_doc_number] => 20030186978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Novel telomerase inhibitors' [patent_app_type] => new [patent_app_number] => 10/311179 [patent_app_country] => US [patent_app_date] => 2003-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7910 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186978.pdf [firstpage_image] =>[orig_patent_app_number] => 10311179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 348888 [patent_doc_number] => 07495004 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-24 [patent_title] => 'Purine derivatives as liver X receptor agonists' [patent_app_type] => utility [patent_app_number] => 10/516168 [patent_app_country] => US [patent_app_date] => 2003-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 122 [patent_figures_cnt] => 122 [patent_no_of_words] => 30862 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/495/07495004.pdf [firstpage_image] =>[orig_patent_app_number] => 10516168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7136279 [patent_doc_number] => 20040043999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Phthalazine derivatives as phosphodiesterase 4-inhibitors' [patent_app_type] => new [patent_app_number] => 10/441177 [patent_app_country] => US [patent_app_date] => 2003-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14221 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20040043999.pdf [firstpage_image] =>[orig_patent_app_number] => 10441177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 948879 [patent_doc_number] => 06962915 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-11-08 [patent_title] => 'Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/440864 [patent_app_country] => US [patent_app_date] => 2003-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13312 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/962/06962915.pdf [firstpage_image] =>[orig_patent_app_number] => 10440864 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7363518 [patent_doc_number] => 20040014962 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => '1-Methylcarbapenem derivatives' [patent_app_type] => new [patent_app_number] => 10/439198 [patent_app_country] => US [patent_app_date] => 2003-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 204920 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014962.pdf [firstpage_image] =>[orig_patent_app_number] => 10439198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6825621 [patent_doc_number] => 20030236243 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-25 [patent_title] => 'Sterically-awkward beta-lactamase inhibitors' [patent_app_type] => new [patent_app_number] => 10/438280 [patent_app_country] => US [patent_app_date] => 2003-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10679 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20030236243.pdf [firstpage_image] =>[orig_patent_app_number] => 10438280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7361936 [patent_doc_number] => 20040014722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases' [patent_app_type] => new [patent_app_number] => 10/437179 [patent_app_country] => US [patent_app_date] => 2003-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13567 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014722.pdf [firstpage_image] =>[orig_patent_app_number] => 10437179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 738087 [patent_doc_number] => 07034150 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-25 [patent_title] => 'Processes for the preparation of carbapenem-type antibacterial agents' [patent_app_type] => utility [patent_app_number] => 10/438649 [patent_app_country] => US [patent_app_date] => 2003-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10644 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/034/07034150.pdf [firstpage_image] =>[orig_patent_app_number] => 10438649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6664560 [patent_doc_number] => 20030203886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-30 [patent_title] => 'Process for the production of clavulanic acid salts' [patent_app_type] => new [patent_app_number] => 10/437097 [patent_app_country] => US [patent_app_date] => 2003-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1962 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20030203886.pdf [firstpage_image] =>[orig_patent_app_number] => 10437097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 517665 [patent_doc_number] => 07193081 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-20 [patent_title] => 'Process for preparation of cyclic prodrugs of PMEA and PMPA' [patent_app_type] => utility [patent_app_number] => 10/436799 [patent_app_country] => US [patent_app_date] => 2003-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9662 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/193/07193081.pdf [firstpage_image] =>[orig_patent_app_number] => 10436799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6679084 [patent_doc_number] => 20030229225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Novel phosphonic acid based prodrugs of PMEA and its analogues' [patent_app_type] => new [patent_app_number] => 10/436922 [patent_app_country] => US [patent_app_date] => 2003-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 25429 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20030229225.pdf [firstpage_image] =>[orig_patent_app_number] => 10436922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468352 [patent_doc_number] => 20040167115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-26 [patent_title] => 'Methods for preventing and treating cancer using N-thiolated beta-lactam compounds and analogs thereof' [patent_app_type] => new [patent_app_number] => 10/431113 [patent_app_country] => US [patent_app_date] => 2003-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 18429 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20040167115.pdf [firstpage_image] =>[orig_patent_app_number] => 10431113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7622201 [patent_doc_number] => 06977300 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-12-20 [patent_title] => 'A2B adenosine receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/431167 [patent_app_country] => US [patent_app_date] => 2003-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31499 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/977/06977300.pdf [firstpage_image] =>[orig_patent_app_number] => 10431167 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6822181 [patent_doc_number] => 20030220342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Imidazo[1, 2-a] pyrazines for the treatment of irritable bowel syndrome' [patent_app_type] => new [patent_app_number] => 10/427234 [patent_app_country] => US [patent_app_date] => 2003-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10294 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20030220342.pdf [firstpage_image] =>[orig_patent_app_number] => 10427234 [rel_patent_id] =>[rel_patent_doc_number] =>)